# Interleukin-10 gene polymorphism (−1082G/A) and allergy to efavirenz in patients infected with human immunodeficiency virus

## Metadata
**Authors:** Raphael de Oliveira Rodrigues, Paulo Germano de Carvalho, Érico Antônio Gomes de Arruda, Silvia Helena Barem Rabenhorst, Silvia Fernandes Ribeiro da Silva, Ilana Farias Ribeiro, Denise Girão Limaverde Lima, Aparecida Tiemi Nagao-Dias
**Journal:** The Brazilian Journal of Infectious Diseases
**Date:** 2014 May 10
**DOI:** [10.1016/j.bjid.2014.01.009](https://doi.org/10.1016/j.bjid.2014.01.009)
**PMID:** 24819158
**PMCID:** PMC9427513
**URL:** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427513/
**PDF:** [https://pmc.ncbi.nlm.nih.gov/articles/PMC9427513/pdf/main.pdf](https://pmc.ncbi.nlm.nih.gov/articles/PMC9427513/pdf/main.pdf)

## Abstract

The aim of the present study was to investigate the association between polymorphism in the interleukin-10 gene promoter at position −1082 in human immunodeficiency virus-infected patients who had presented allergic reaction due to efavirenz. The study included 63 patients treated at the Hospital São José de Doenças Infecciosas, Fortaleza, Ceará, Brazil. Twenty-one patients who had presented allergic reaction to efavirenz were compared to 42 patients with no allergic reaction following exposure to this drug. Blood samples were collected for DNA extraction and submitted to the restriction fragment length polymorphism – polymerase chain reaction technique. The −1082AA genotype was significantly more frequent in allergic patients as compared to non-allergic patients (p = 0.019; χ2 = 5.534; OR = 3.625; 95% CI = 1.210–10.860). Likewise the allele IL-10 −1082A was identified significantly more often among efavirenz allergic patients than in the non-allergic group (p = 0.009; χ2 = 6.787; OR = 3.029; 95% CI = 1.290–7.111). These findings suggest that the polymorphism in the interleukin-10 gene promoter −1082G/A can be related to the development of allergic reactions to efavirenz.

Keywords: HIV, Drug allergy, Polymorphism, IL-10

## Conflicts of interest

The authors declare no conflicts of interest.

## Acknowledgement

This study was financially supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, process 554970/2010-4).

## References

1. Edwards I.R., Aronson J.K. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255–1259. doi: 10.1016/S0140-6736(00)02799-9.  [DOI](https://doi.org/10.1016/S0140-6736(00)02799-9) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/11072960/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Lancet&title=Adverse%20drug%20reactions:%20definitions,%20diagnosis,%20and%20management&author=I.R.%20Edwards&author=J.K.%20Aronson&volume=356&publication_year=2000&pages=1255-1259&pmid=11072960&doi=10.1016/S0140-6736(00)02799-9&)

2. Montessori V., Press N., Harris M., Akagi L., Montaner J.S.G. Adverse effects of antiretroviral therapy for HIV infection. CMAJ. 2004;170:229–238.  [PMC free article](/articles/PMC315530/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/14734438/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=CMAJ&title=Adverse%20effects%20of%20antiretroviral%20therapy%20for%20HIV%20infection&author=V.%20Montessori&author=N.%20Press&author=M.%20Harris&author=L.%20Akagi&author=J.S.G.%20Montaner&volume=170&publication_year=2004&pages=229-238&pmid=14734438&)

3. Pirmohamed M., Park K. HIV and drug allergy. Curr Opin Allergy Clin Immunol. 2001;1:311–316. doi: 10.1097/01.all.0000011032.69243.10.  [DOI](https://doi.org/10.1097/01.all.0000011032.69243.10) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/11964706/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Curr%20Opin%20Allergy%20Clin%20Immunol&title=HIV%20and%20drug%20allergy&author=M.%20Pirmohamed&author=K.%20Park&volume=1&publication_year=2001&pages=311-316&pmid=11964706&doi=10.1097/01.all.0000011032.69243.10&)

4. Carr A., Cooper D.A. Adverse effects of antiretroviral therapy. Lancet. 2000;356:1423–1430. doi: 10.1016/S0140-6736(00)02854-3.  [DOI](https://doi.org/10.1016/S0140-6736(00)02854-3) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/11052597/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Lancet&title=Adverse%20effects%20of%20antiretroviral%20therapy&author=A.%20Carr&author=D.A.%20Cooper&volume=356&publication_year=2000&pages=1423-1430&pmid=11052597&doi=10.1016/S0140-6736(00)02854-3&)

5. Temesgen Z., Beri G. HIV and drug allergy. Immunol Allergy Clin N Am. 2004;24:521–531. doi: 10.1016/j.iac.2004.03.006.  [DOI](https://doi.org/10.1016/j.iac.2004.03.006) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/15242725/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Immunol%20Allergy%20Clin%20N%20Am&title=HIV%20and%20drug%20allergy&author=Z.%20Temesgen&author=G.%20Beri&volume=24&publication_year=2004&pages=521-531&pmid=15242725&doi=10.1016/j.iac.2004.03.006&)

6. Mallal S., Nolan D., Witt C., et al. Association between presence of HLAB*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse transcriptase inhibitor abacavir. Lancet. 2002;359:727–732. doi: 10.1016/s0140-6736(02)07873-x.  [DOI](https://doi.org/10.1016/s0140-6736(02)07873-x) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/11888582/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Lancet&title=Association%20between%20presence%20of%20HLAB*5701,%20HLA-DR7,%20and%20HLA-DQ3%20and%20hypersensitivity%20to%20HIV-1%20reverse%20transcriptase%20inhibitor%20abacavir&author=S.%20Mallal&author=D.%20Nolan&author=C.%20Witt&volume=359&publication_year=2002&pages=727-732&pmid=11888582&doi=10.1016/s0140-6736(02)07873-x&)

7. Saag M., Balu R., Phillips E., et al. High sensitivity of human leukocyte antigen-B*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients. Clin Infect Dis. 2008;46:1111–1118. doi: 10.1086/529382.  [DOI](https://doi.org/10.1086/529382) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/18444831/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clin%20Infect%20Dis&title=High%20sensitivity%20of%20human%20leukocyte%20antigen-B*5701%20as%20a%20marker%20for%20immunologically%20confirmed%20abacavir%20hypersensitivity%20in%20white%20and%20black%20patients&author=M.%20Saag&author=R.%20Balu&author=E.%20Phillips&volume=46&publication_year=2008&pages=1111-1118&pmid=18444831&doi=10.1086/529382&)

8. Mallal S., Phillips E., Carosi G., et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Eng J Med. 2008;358:568–579. doi: 10.1056/NEJMoa0706135.  [DOI](https://doi.org/10.1056/NEJMoa0706135) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/18256392/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=N%20Eng%20J%20Med&title=HLA-B*5701%20screening%20for%20hypersensitivity%20to%20abacavir&author=S.%20Mallal&author=E.%20Phillips&author=G.%20Carosi&volume=358&publication_year=2008&pages=568-579&pmid=18256392&doi=10.1056/NEJMoa0706135&)

9. Visentainer J.E.L., Sell A.M., Franceschi D.A., Lieber S.R., Souza C.A. Importance of regulatory cytokine gene polymorphisms in hematopoietic stem cell transplantation. Braz J Pharm Sci. 2008;44:739–748.  [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Braz%20J%20Pharm%20Sci&title=Importance%20of%20regulatory%20cytokine%20gene%20polymorphisms%20in%20hematopoietic%20stem%20cell%20transplantation&author=J.E.L.%20Visentainer&author=A.M.%20Sell&author=D.A.%20Franceschi&author=S.R.%20Lieber&author=C.A.%20Souza&volume=44&publication_year=2008&pages=739-748&)

10. Moore K.W., de Waal Malefyt R., Coffman R.L., O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683–765. doi: 10.1146/annurev.immunol.19.1.683.  [DOI](https://doi.org/10.1146/annurev.immunol.19.1.683) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/11244051/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Annu%20Rev%20Immunol&title=Interleukin-10%20and%20the%20interleukin-10%20receptor&author=K.W.%20Moore&author=R.%20de%20Waal%20Malefyt&author=R.L.%20Coffman&author=A.%20O%E2%80%99Garra&volume=19&publication_year=2001&pages=683-765&pmid=11244051&doi=10.1146/annurev.immunol.19.1.683&)

11. Turner D.M., Willians D.M., Sankaran D., Lazarus M., Sinnot P.J., Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1–8. doi: 10.1111/j.1365-2370.1997.tb00001.x.  [DOI](https://doi.org/10.1111/j.1365-2370.1997.tb00001.x) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/9043871/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Immunogenet&title=An%20investigation%20of%20polymorphism%20in%20the%20interleukin-10%20gene%20promoter&author=D.M.%20Turner&author=D.M.%20Willians&author=D.%20Sankaran&author=M.%20Lazarus&author=P.J.%20Sinnot&volume=24&publication_year=1997&pages=1-8&pmid=9043871&doi=10.1111/j.1365-2370.1997.tb00001.x&)

12. Reuss E., Fimmers R., Kruger A., Becker C., Rittner C., Höhler T. Differential regulation of interleukin-10 production by genetic and environmental factors – a twin study. Genes Immun. 2002;3:407–413. doi: 10.1038/sj.gene.6363920.  [DOI](https://doi.org/10.1038/sj.gene.6363920) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/12424622/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Genes%20Immun&title=Differential%20regulation%20of%20interleukin-10%20production%20by%20genetic%20and%20environmental%20factors%20%E2%80%93%20a%20twin%20study&author=E.%20Reuss&author=R.%20Fimmers&author=A.%20Kruger&author=C.%20Becker&author=C.%20Rittner&volume=3&publication_year=2002&pages=407-413&pmid=12424622&doi=10.1038/sj.gene.6363920&)

13. Koch W., Kastrati A., Böttiger C., Mehilli J., von Beckerath N., Schömig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis. 2001;159:137–144. doi: 10.1016/s0021-9150(01)00467-1.  [DOI](https://doi.org/10.1016/s0021-9150(01)00467-1) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/11689215/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Atherosclerosis&title=Interleukin-10%20and%20tumor%20necrosis%20factor%20gene%20polymorphisms%20and%20risk%20of%20coronary%20artery%20disease%20and%20myocardial%20infarction&author=W.%20Koch&author=A.%20Kastrati&author=C.%20B%C3%B6ttiger&author=J.%20Mehilli&author=N.%20von%20Beckerath&volume=159&publication_year=2001&pages=137-144&pmid=11689215&doi=10.1016/s0021-9150(01)00467-1&)

14. Metzger I.F., Souza-Costa D.C., Tanus-Santos J.E. Pharmacogenetic: principles, applications and perspectives. Med Ribeirão Preto. 2006;39:515–521.  [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Med%20Ribeir%C3%A3o%20Preto&title=Pharmacogenetic:%20principles,%20applications%20and%20perspectives&author=I.F.%20Metzger&author=D.C.%20Souza-Costa&author=J.E.%20Tanus-Santos&volume=39&publication_year=2006&pages=515-521&)

15. Weinshilboum R.M., Wang L. Pharmacogenetics and pharmacogenomics: development, science, and translation. Annu Rev Genomics Hum Genet. 2006;7:223–245. doi: 10.1146/annurev.genom.6.080604.162315.  [DOI](https://doi.org/10.1146/annurev.genom.6.080604.162315) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/16948615/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Annu%20Rev%20Genomics%20Hum%20Genet&title=Pharmacogenetics%20and%20pharmacogenomics:%20development,%20science,%20and%20translation&author=R.M.%20Weinshilboum&author=L.%20Wang&volume=7&publication_year=2006&pages=223-245&pmid=16948615&doi=10.1146/annurev.genom.6.080604.162315&)

16. Cordeiro C.A., Moreira P.R., Andrade M.S., et al. Interleukin-10 gene polymorphism (−1082G/A) is associated with toxoplasmic retinochoroiditis. Invest Ophthalmol Vis Sci. 2008;49:1979–1982. doi: 10.1167/iovs.07-1393.  [DOI](https://doi.org/10.1167/iovs.07-1393) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/18436829/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Invest%20Ophthalmol%20Vis%20Sci&title=Interleukin-10%20gene%20polymorphism%20(%E2%88%921082G/A)%20is%20associated%20with%20toxoplasmic%20retinochoroiditis&author=C.A.%20Cordeiro&author=P.R.%20Moreira&author=M.S.%20Andrade&volume=49&publication_year=2008&pages=1979-1982&pmid=18436829&doi=10.1167/iovs.07-1393&)

17. Costa G.C., Rocha M.O.C., Moreira P.R., et al. Functional IL-10 gene polymorphism is associated with chagas disease cardiomyopathy. J Infect Dis. 2009;199:451–454. doi: 10.1086/596061.  [DOI](https://doi.org/10.1086/596061) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/19099482/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J%20Infect%20Dis&title=Functional%20IL-10%20gene%20polymorphism%20is%20associated%20with%20chagas%20disease%20cardiomyopathy&author=G.C.%20Costa&author=M.O.C.%20Rocha&author=P.R.%20Moreira&volume=199&publication_year=2009&pages=451-454&pmid=19099482&doi=10.1086/596061&)

18. Guglielmi L., Fontaine C., Gougat C., et al. IL-10 promoter and IL4-Rα gene SNPs are associated with immediate β-lactam allergy in atopic women. Allergy. 2006;61:921–927. doi: 10.1111/j.1398-9995.2006.01067.x.  [DOI](https://doi.org/10.1111/j.1398-9995.2006.01067.x) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/16867043/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Allergy&title=IL-10%20promoter%20and%20IL4-R%CE%B1%20gene%20SNPs%20are%20associated%20with%20immediate%20%CE%B2-lactam%20allergy%20in%20atopic%20women&author=L.%20Guglielmi&author=C.%20Fontaine&author=C.%20Gougat&volume=61&publication_year=2006&pages=921-927&pmid=16867043&doi=10.1111/j.1398-9995.2006.01067.x&)

19. Qiao H.L., Yang J., Zhang Y.W. Relationships between specific serum IgE, cytokines and polymorphisms in the IL-4, IL-4Ra in patients with penicillins allergy. Allergy. 2005;60:1053–1059. doi: 10.1111/j.1398-9995.2005.00816.x.  [DOI](https://doi.org/10.1111/j.1398-9995.2005.00816.x) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/15969687/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Allergy&title=Relationships%20between%20specific%20serum%20IgE,%20cytokines%20and%20polymorphisms%20in%20the%20IL-4,%20IL-4Ra%20in%20patients%20with%20penicillins%20allergy&author=H.L.%20Qiao&author=J.%20Yang&author=Y.W.%20Zhang&volume=60&publication_year=2005&pages=1053-1059&pmid=15969687&doi=10.1111/j.1398-9995.2005.00816.x&)

20. Pichler W., Yawalkar N., Schmid S., Helbling A. Pathogenesis of drug-induced exanthems. Allergy. 2002;57:884–893. doi: 10.1034/j.1398-9995.2002.02161.x.  [DOI](https://doi.org/10.1034/j.1398-9995.2002.02161.x) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/12269933/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Allergy&title=Pathogenesis%20of%20drug-induced%20exanthems&author=W.%20Pichler&author=N.%20Yawalkar&author=S.%20Schmid&author=A.%20Helbling&volume=57&publication_year=2002&pages=884-893&pmid=12269933&doi=10.1034/j.1398-9995.2002.02161.x&)
